Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank Disease ID
1 AGE-RAGE signaling pathway in diabetic complications 💬
[1] IL1A 💬 Bermekimab 💬 Bermekimab [1] 51 💬
2 AGE-RAGE signaling pathway in diabetic complications 💬
[1] IL1A 💬 Lutikizumab 💬 Lutikizumab [3] 46, 96, 97 💬
3 AGE-RAGE signaling pathway in diabetic complications 💬
[1] IL1A 💬 Pirfenidone 💬 Pirfenidone [12] 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
4 AGE-RAGE signaling pathway in diabetic complications 💬
[1] IL1A 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
5 AGE-RAGE signaling pathway in diabetic complications 💬
[1] IL1A 💬 Vilamakitug 💬 Vilamakitug [1] 271 💬
6 Alzheimer disease 💬
[1] IL1A 💬 Bermekimab 💬 Bermekimab [1] 51 💬
7 Alzheimer disease 💬
[1] IL1A 💬 Lutikizumab 💬 Lutikizumab [3] 46, 96, 97 💬
8 Alzheimer disease 💬
[1] IL1A 💬 Pirfenidone 💬 Pirfenidone [12] 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
9 Alzheimer disease 💬
[1] IL1A 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
10 Alzheimer disease 💬
[1] IL1A 💬 Vilamakitug 💬 Vilamakitug [1] 271 💬
11 Cellular senescence 💬
[1] IL1A 💬 Bermekimab 💬 Bermekimab [1] 51 💬
12 Cellular senescence 💬
[1] IL1A 💬 Lutikizumab 💬 Lutikizumab [3] 46, 96, 97 💬
13 Cellular senescence 💬
[1] IL1A 💬 Pirfenidone 💬 Pirfenidone [12] 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
14 Cellular senescence 💬
[1] IL1A 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
15 Cellular senescence 💬
[1] IL1A 💬 Vilamakitug 💬 Vilamakitug [1] 271 💬
16 Cytokine-cytokine receptor interaction 💬
[1] IL1A 💬 Bermekimab 💬 Bermekimab [1] 51 💬
17 Cytokine-cytokine receptor interaction 💬
[1] IL1A 💬 Lutikizumab 💬 Lutikizumab [3] 46, 96, 97 💬
18 Cytokine-cytokine receptor interaction 💬
[1] IL1A 💬 Pirfenidone 💬 Pirfenidone [12] 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
19 Cytokine-cytokine receptor interaction 💬
[1] IL1A 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
20 Cytokine-cytokine receptor interaction 💬
[1] IL1A 💬 Vilamakitug 💬 Vilamakitug [1] 271 💬
21 Fluid shear stress and atherosclerosis 💬
[1] IL1A 💬 Bermekimab 💬 Bermekimab [1] 51 💬
22 Fluid shear stress and atherosclerosis 💬
[1] IL1A 💬 Lutikizumab 💬 Lutikizumab [3] 46, 96, 97 💬
23 Fluid shear stress and atherosclerosis 💬
[1] IL1A 💬 Pirfenidone 💬 Pirfenidone [12] 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
24 Fluid shear stress and atherosclerosis 💬
[1] IL1A 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
25 Fluid shear stress and atherosclerosis 💬
[1] IL1A 💬 Vilamakitug 💬 Vilamakitug [1] 271 💬
26 Graft-versus-host disease 💬
[1] IL1A 💬 Bermekimab 💬 Bermekimab [1] 51 💬
27 Graft-versus-host disease 💬
[1] IL1A 💬 Lutikizumab 💬 Lutikizumab [3] 46, 96, 97 💬
28 Graft-versus-host disease 💬
[1] IL1A 💬 Pirfenidone 💬 Pirfenidone [12] 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
29 Graft-versus-host disease 💬
[1] IL1A 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
30 Graft-versus-host disease 💬
[1] IL1A 💬 Vilamakitug 💬 Vilamakitug [1] 271 💬
31 Hematopoietic cell lineage 💬
[1] IL1A 💬 Bermekimab 💬 Bermekimab [1] 51 💬
32 Hematopoietic cell lineage 💬
[1] IL1A 💬 Lutikizumab 💬 Lutikizumab [3] 46, 96, 97 💬
33 Hematopoietic cell lineage 💬
[1] IL1A 💬 Pirfenidone 💬 Pirfenidone [12] 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
34 Hematopoietic cell lineage 💬
[1] IL1A 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
35 Hematopoietic cell lineage 💬
[1] IL1A 💬 Vilamakitug 💬 Vilamakitug [1] 271 💬
36 Inflammatory bowel disease 💬
[1] IL1A 💬 Bermekimab 💬 Bermekimab [1] 51 💬
37 Inflammatory bowel disease 💬
[1] IL1A 💬 Lutikizumab 💬 Lutikizumab [3] 46, 96, 97 💬
38 Inflammatory bowel disease 💬
[1] IL1A 💬 Pirfenidone 💬 Pirfenidone [12] 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
39 Inflammatory bowel disease 💬
[1] IL1A 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
40 Inflammatory bowel disease 💬
[1] IL1A 💬 Vilamakitug 💬 Vilamakitug [1] 271 💬
41 Influenza A 💬
[1] IL1A 💬 Bermekimab 💬 Bermekimab [1] 51 💬
42 Influenza A 💬
[1] IL1A 💬 Lutikizumab 💬 Lutikizumab [3] 46, 96, 97 💬
43 Influenza A 💬
[1] IL1A 💬 Pirfenidone 💬 Pirfenidone [12] 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
44 Influenza A 💬
[1] IL1A 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
45 Influenza A 💬
[1] IL1A 💬 Vilamakitug 💬 Vilamakitug [1] 271 💬
46 Leishmaniasis 💬
[1] IL1A 💬 Bermekimab 💬 Bermekimab [1] 51 💬
47 Leishmaniasis 💬
[1] IL1A 💬 Lutikizumab 💬 Lutikizumab [3] 46, 96, 97 💬
48 Leishmaniasis 💬
[1] IL1A 💬 Pirfenidone 💬 Pirfenidone [12] 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
49 Leishmaniasis 💬
[1] IL1A 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
50 Leishmaniasis 💬
[1] IL1A 💬 Vilamakitug 💬 Vilamakitug [1] 271 💬
51 MAPK signaling pathway 💬
[1] IL1A 💬 Bermekimab 💬 Bermekimab [1] 51 💬
52 MAPK signaling pathway 💬
[1] IL1A 💬 Lutikizumab 💬 Lutikizumab [3] 46, 96, 97 💬
53 MAPK signaling pathway 💬
[1] IL1A 💬 Pirfenidone 💬 Pirfenidone [12] 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
54 MAPK signaling pathway 💬
[1] IL1A 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
55 MAPK signaling pathway 💬
[1] IL1A 💬 Vilamakitug 💬 Vilamakitug [1] 271 💬
56 Measles 💬
[1] IL1A 💬 Bermekimab 💬 Bermekimab [1] 51 💬
57 Measles 💬
[1] IL1A 💬 Lutikizumab 💬 Lutikizumab [3] 46, 96, 97 💬
58 Measles 💬
[1] IL1A 💬 Pirfenidone 💬 Pirfenidone [12] 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
59 Measles 💬
[1] IL1A 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
60 Measles 💬
[1] IL1A 💬 Vilamakitug 💬 Vilamakitug [1] 271 💬
61 Necroptosis 💬
[1] IL1A 💬 Bermekimab 💬 Bermekimab [1] 51 💬
62 Necroptosis 💬
[1] IL1A 💬 Lutikizumab 💬 Lutikizumab [3] 46, 96, 97 💬
63 Necroptosis 💬
[1] IL1A 💬 Pirfenidone 💬 Pirfenidone [12] 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
64 Necroptosis 💬
[1] IL1A 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
65 Necroptosis 💬
[1] IL1A 💬 Vilamakitug 💬 Vilamakitug [1] 271 💬
66 Non-alcoholic fatty liver disease 💬
[1] IL1A 💬 Bermekimab 💬 Bermekimab [1] 51 💬
67 Non-alcoholic fatty liver disease 💬
[1] IL1A 💬 Lutikizumab 💬 Lutikizumab [3] 46, 96, 97 💬
68 Non-alcoholic fatty liver disease 💬
[1] IL1A 💬 Pirfenidone 💬 Pirfenidone [12] 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
69 Non-alcoholic fatty liver disease 💬
[1] IL1A 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
70 Non-alcoholic fatty liver disease 💬
[1] IL1A 💬 Vilamakitug 💬 Vilamakitug [1] 271 💬
71 Osteoclast differentiation 💬
[1] IL1A 💬 Bermekimab 💬 Bermekimab [1] 51 💬
72 Osteoclast differentiation 💬
[1] IL1A 💬 Lutikizumab 💬 Lutikizumab [3] 46, 96, 97 💬
73 Osteoclast differentiation 💬
[1] IL1A 💬 Pirfenidone 💬 Pirfenidone [12] 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
74 Osteoclast differentiation 💬
[1] IL1A 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
75 Osteoclast differentiation 💬
[1] IL1A 💬 Vilamakitug 💬 Vilamakitug [1] 271 💬
76 Pathways of neurodegeneration - multiple diseases 💬
[1] IL1A 💬 Bermekimab 💬 Bermekimab [1] 51 💬
77 Pathways of neurodegeneration - multiple diseases 💬
[1] IL1A 💬 Lutikizumab 💬 Lutikizumab [3] 46, 96, 97 💬
78 Pathways of neurodegeneration - multiple diseases 💬
[1] IL1A 💬 Pirfenidone 💬 Pirfenidone [12] 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
79 Pathways of neurodegeneration - multiple diseases 💬
[1] IL1A 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
80 Pathways of neurodegeneration - multiple diseases 💬
[1] IL1A 💬 Vilamakitug 💬 Vilamakitug [1] 271 💬
81 Pertussis 💬
[1] IL1A 💬 Bermekimab 💬 Bermekimab [1] 51 💬
82 Pertussis 💬
[1] IL1A 💬 Lutikizumab 💬 Lutikizumab [3] 46, 96, 97 💬
83 Pertussis 💬
[1] IL1A 💬 Pirfenidone 💬 Pirfenidone [12] 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
84 Pertussis 💬
[1] IL1A 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
85 Pertussis 💬
[1] IL1A 💬 Vilamakitug 💬 Vilamakitug [1] 271 💬
86 Prion disease 💬
[1] IL1A 💬 Bermekimab 💬 Bermekimab [1] 51 💬
87 Prion disease 💬
[1] IL1A 💬 Lutikizumab 💬 Lutikizumab [3] 46, 96, 97 💬
88 Prion disease 💬
[1] IL1A 💬 Pirfenidone 💬 Pirfenidone [12] 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
89 Prion disease 💬
[1] IL1A 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
90 Prion disease 💬
[1] IL1A 💬 Vilamakitug 💬 Vilamakitug [1] 271 💬
91 Rheumatoid arthritis 💬
[1] IL1A 💬 Bermekimab 💬 Bermekimab [1] 51 💬
92 Rheumatoid arthritis 💬
[1] IL1A 💬 Lutikizumab 💬 Lutikizumab [3] 46, 96, 97 💬
93 Rheumatoid arthritis 💬
[1] IL1A 💬 Pirfenidone 💬 Pirfenidone [12] 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
94 Rheumatoid arthritis 💬
[1] IL1A 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
95 Rheumatoid arthritis 💬
[1] IL1A 💬 Vilamakitug 💬 Vilamakitug [1] 271 💬
96 Tuberculosis 💬
[1] IL1A 💬 Bermekimab 💬 Bermekimab [1] 51 💬
97 Tuberculosis 💬
[1] IL1A 💬 Lutikizumab 💬 Lutikizumab [3] 46, 96, 97 💬
98 Tuberculosis 💬
[1] IL1A 💬 Pirfenidone 💬 Pirfenidone [12] 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
99 Tuberculosis 💬
[1] IL1A 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
100 Tuberculosis 💬
[1] IL1A 💬 Vilamakitug 💬 Vilamakitug [1] 271 💬
101 Type I diabetes mellitus 💬
[1] IL1A 💬 Bermekimab 💬 Bermekimab [1] 51 💬
102 Type I diabetes mellitus 💬
[1] IL1A 💬 Lutikizumab 💬 Lutikizumab [3] 46, 96, 97 💬
103 Type I diabetes mellitus 💬
[1] IL1A 💬 Pirfenidone 💬 Pirfenidone [12] 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
104 Type I diabetes mellitus 💬
[1] IL1A 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
105 Type I diabetes mellitus 💬
[1] IL1A 💬 Vilamakitug 💬 Vilamakitug [1] 271 💬